CRISPR Therapeutics AG (CRSP) Assets (2015 - 2026)
CRISPR Therapeutics AG's Assets came in at $2.65 billion for Q2 2026, up 30.6% from $2.03 billion a year earlier but down 2.8% from the prior quarter.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Assets (2015 - 2026) Analysis & Trends
At the end of FY2025, CRISPR Therapeutics AG's Assets was $2.27 billion, up 1.0% from FY2024.
- Assets carries a five-year compound annual growth rate of 4.4% (FY2020 to FY2025).
- Going back by year, Assets was $2.24 billion in FY2024 (+0.6%), $2.23 billion in FY2023 (-0.6%), $2.24 billion in FY2022 (-18.5%) and $2.75 billion in FY2021 (+50.5%).
- The five-year range for quarterly Assets is $2.03 billion (Q2 2025) to $2.82 billion (Q3 2021).
- Year-over-year, Assets has increased for three consecutive quarters, with growth averaging 5.2% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q3 2021 (growth of 90.0%), and the weakest in Q4 2022 (a decline of 18.5%).
- Business Quant data shows CRSP's Assets at $2.73 billion (Q1 2026), $2.27 billion (Q4 2025) and $2.25 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 201.13 Bn |
| 10 | CRISPR Therapeutics AG | 4.88 Bn | -3.82 Bn | - | 2.65 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.65 Bn |
| Mar 31, 2026 | 2.73 Bn |
| Dec 31, 2025 | 2.27 Bn |
| Sep 30, 2025 | 2.25 Bn |
| Jun 30, 2025 | 2.03 Bn |
| Mar 31, 2025 | 2.17 Bn |
| Dec 31, 2024 | 2.24 Bn |
| Sep 30, 2024 | 2.26 Bn |
| Jun 30, 2024 | 2.34 Bn |
| Mar 31, 2024 | 2.44 Bn |
| Dec 31, 2023 | 2.23 Bn |
| Sep 30, 2023 | 2.09 Bn |
| Jun 30, 2023 | 2.20 Bn |
| Mar 31, 2023 | 2.24 Bn |
| Dec 31, 2022 | 2.24 Bn |
| Sep 30, 2022 | 2.35 Bn |
| Jun 30, 2022 | 2.46 Bn |
| Mar 31, 2022 | 2.61 Bn |
| Dec 31, 2021 | 2.75 Bn |
| Sep 30, 2021 | 2.82 Bn |
API Access
CRISPR Therapeutics AG Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();